Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Countries
Countries
Switzerland
Products 1 to 10 of 19
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Antibiotic - EV-035
by
Emergent Biosolutions, Inc.
Biotech components:
Bacteria
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
+
Switzerland
Intended consumer:
Government
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
86,000,000 CHF
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
EVE
(SWX)
Value chain stage:
Finished Product
BIO-SA Based Resins & Coatings
by
BioAmber, Inc.
Biotech components:
Plant
Business models:
B2C
Country of production:
Canada
Country of distribution:
Benelux
+
France
+
Iberia
+
Germany
+
Poland
+
Switzerland
+
UK
+
Ireland
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 14:30 (5 years ago)
Known funding amount:
155,600,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Finished Product
Cellular Implant for Detection of Hypercalcemia Associated with Cancer
by
ETH Zurich
Biotech components:
Gene Editing
Business models:
B2C
Country of production:
Switzerland
Country of distribution:
Switzerland
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/08 14:47 (6 years ago)
Known funding amount:
N/A
Funding types:
Government
Industry:
Health
Market status:
Early Stage Concept
Organization type(s):
Research Institution
+
University
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Clearwood (TM) Patchouli Oil
by
Amyris
+
Firmenich
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
+
Switzerland
Country of distribution:
Switzerland
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/02/15 12:43 (5 years ago)
Known funding amount:
471,900,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Personal Care (Topical)
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
AMRS
(NASDAQ)
Value chain stage:
Finished Product
CRISPR-Cas9
by
CRISPR
Biotech components:
Molecule
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
N/A
Intended consumer:
Research
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 13:59 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Science
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Research
Production process:
Closed Production
Source:
Web search
Trading symbol:
CRSP
(NASDAQ)
Value chain stage:
Finished Product
Deltazym® APS protease
by
BASF
Biotech components:
Molecule
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
USA
+
Canada
+
Switzerland
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/05/15 15:47 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
Open Release
Source:
Web search
Trading symbol:
BAS
(ETR)
Value chain stage:
Input
Detalzym GA L-E5 Glucoamylase
by
BASF
+
Verenium
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
Germany
+
USA
+
China
+
Japan
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/12/26 15:16 (5 years ago)
Known funding amount:
2,147,483,647 EUR
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
No longer on the market
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BAS
(ETR)
Value chain stage:
Input
Eradicake Alpha-Amylase
by
BASF
+
Verenium
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
USA
+
Mexico
+
Canada
+
Germany
+
Singapore
+
Brazil
+
China
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/12/26 15:23 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BAS
(ETR)
Value chain stage:
Input
EveNootkatone
by
Evolva
Biotech components:
Plant
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
USA
+
Europe
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
86,000,000 CHF
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Additive
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
EVE
(SWX)
Value chain stage:
Input
EverSweet™
by
Evolva
+
Cargill
Biotech components:
Plant
Business models:
B2B
+
B2C
Country of production:
Switzerland
Country of distribution:
USA
+
Europe
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/09/13 15:54 (6 years ago)
Known funding amount:
86,000,000 CHF
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Chemical
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
EVE
(SWX)
Value chain stage:
Input
1
2
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
